$AGYS

SRINIVASAN RAMESH sold $21.3M of AGYS

SRINIVASAN RAMESH (President & CEO) sold 197,410 shares of AGILYSYS INC (AGYS) at an average of $107.82 ($106.60–$109.63, $21.29M total) across 4 trades over 2026-08-05 to 2026-08-07.

Original reporting
SEC EDGAR · SRINIVASAN RAMESH
Published Aug 7, 2026, 9:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 9:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AGYS
Neutral
medium confidence
Mentioned
$AGYS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AGYSNeutralLow
01

Why it matters

The market may reprice short-term sentiment around insider confidence, but there is no accompanying guidance, deal, or operational update in the text.

02

Market read

A large CEO sale is disclosed, which can affect near-term sentiment and options positioning, but it does not provide new fundamentals.

03

What to watch

The absence of a stated 10b5-1 plan can increase perceived risk, but without additional context (e.g., compensation structure, tax events) it is hard to infer intent.

Relevance 7/10Novelty 5/10Timing: filed 2026-08-07, covering sales executed 2026-08-05 to 2026-08-07

Background

This is an SEC Form 4 insider transaction by AGILYSYS President and CEO Srinivasan Ramesh.

Company-level read

Ticker impact

$AGYSNeutralMedium confidence
Context

AGILYSYS CEO sold about $21.29M of AGYS shares in four open-market trades from 2026-08-05 to 2026-08-07.

Expected impact

Likely modest negative bias for the next few sessions, with limited follow-through unless accompanied by other disclosures.

Evidence & confidence

The filing is a primary Form 4 disclosure with sizable value, but it does not include new company fundamentals or a 10b5-1 plan, so the market may treat it as mixed signal rather than a catalyst.

Market effects

Limited sector read-through; this is company-specific insider activity rather than an industry shock.

No clear regional spillover indicated by the filing alone.

Minimal global relevance; the disclosure is localized to AGILYSYS insider trading.

Counterpoint

The CEO may be selling for diversification, taxes, or pre-planned liquidity needs, so the signal could be largely non-informational.

Key entities

  • AGILYSYS INC

    US-listed company whose CEO executed open-market sales totaling about $21.29M.

  • SRINIVASAN RAMESH

    President and CEO who sold 197,410 shares across four trades at $106.60 to $109.63.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MANHMed

Manhattan Associates, Agilysys, Guidewire Software, Pegasystems, and Teradata Stocks Trade Up, What You Need To Know

Shares of Manhattan Associates, Agilysys, Guidewire Software, Pegasystems, and Teradata rose in afternoon trading after strong quarterly earnings and optimistic corporate commentary about AI-driven growth in enterprise software. Salesforce, CrowdStrike, and Okta reported significant AI-related revenue increases, easing investor concerns about AI disruption. Pegasystems' stock is down 36.2% year-to-date but saw a 6.2% increase on the day.

$AGYSHighAI 8/10

Why Agilysys (AGYS) Stock Is Up Today

Agilysys (NASDAQ: AGYS) shares rose 11.6% after the company reported Q2 results above expectations and raised full-year revenue guidance. Revenue was $87.68M vs $86.2M expected, with adjusted EPS $0.49 vs $0.40. Full-year revenue guidance midpoint was lifted to $370.5M.

$AGYSMed

Agilysys Inc (AGYS) Q1 2027 Earnings Call Highlights: Record Revenue and Raised Guidance

Agilysys (AGYS) reported Q1 2027 earnings call highlights, citing record revenue and raised guidance. The CFO said the increase was driven by stronger-than-expected subscription sales and backlog conversion, while product and professional services remain within prior guidance. CEO comments covered RFP win rates, Marriott PMS rollout lessons, price-sensitive markets, and AI’s role in hospitality software.

$AGYSMedAI 8/10

Agilysys: Fiscal Q1 Earnings Snapshot

Agilysys Inc. (AGYS) reported fiscal Q1 profit of 32 cents per share, or 49 cents adjusted, versus Zacks’ four-analyst estimate of 40 cents. Revenue was $87.7 million versus $85.9 million expected. Full-year revenue guidance is $368 million to $373 million. Shares were down 13% YTD, ending Monday at $103.24.